A brief article on Cosmetovigilence the ongoing and systematic monitoring of safety and adverse effects of cosmetics

  • Ramisetty Sailaja Priyadarshini Institute of Pharmaceutical Education and Research, 5th Mile, Pulladigunta, Guntur-522017.Andhra Pradesh, India.

Abstract

Cosmetovigilence is the study of cosmetic products from a public health perspective. The Saudi Food and Drug Authority has assumed responsibility for regulating cosmetic items and issuing recommendations to ensure their safety due to the drastic growth of beauty products in Saudi Arabia. Addressing the safety of cosmetic goods is widely recognized as a public health concept. In tertiary care hospitals, identify potentially dangerous impacts from cosmetic goods and take appropriate action to prevent them. The goals of this text are to cater to the demands of dermatologists, scientists, cosmetic chemists, and formulators who have to grasp a variety of topics in order to develop innovative, successful skin care products for a particular market. In addition to chemicals, physical and biological risk factors also manifest in the skin, which is the biggest organ in the body.

Keywords: Cosmetics, Cosmetovigilence, skincare products, health care products, awareness, appearance

Downloads

Download data is not yet available.

References

1. Food S, Authority D. Cosmetics [WWW Document]. URL https://www. sfda. gov. sa/en/cosmetic/Pages/cosmetic_product. aspx (accessed 1.6. 20). 2008.
2. Nanjwade BK, Bechra HM, Derkar GK, Manvi FV, Nanjwade VK. Dendrimers: emerging polymers for drug-delivery systems. European Journal of Pharmaceutical Sciences. 2009 Oct 8;38(3):185-96.
3. World Health Organization. Safety monitoring of medical products: reporting system for the general public.
4. Dini I, Laneri S. Nutricosmetics: A brief overview. Phytotherapy Research. 2019 Dec;33(12):3054-63.
5. Singh BG, Baburao C, Pispati V, Pathipati H, Muthy N, Prassana SR, Rathode BG. Carbon nanotubes. A novel drug delivery system. International Journal of Research in Pharmacy and Chemistry. 2012;2(2):523-32.
6. Dhara RS, Dhande PP, Karandikar YS, Sahasrabudhe RA, Pandit VA. Impact of series of interventions on clinicians’ awareness about pharmacovigilance system in Western India. Asian J Pharm Clin Res. 2014;7:14-20.
7. Rao, A Anka;,Rao, CH Babu, Devanna, N. 2017. DESIGN AND EVALUATION OF MUCOADHESIVE BUCCAL BILAYERED TABLETS OF METOPROLOL SUCCINATE. World journal of Pharmaceutical research.Vol.7.Issue.3.page-172-178.
8. pharmacovigilance system for cosmetics developed by the French health products safety agency. A proposal for the future. Therapie 2002;57:273-82.
9. Dey B, Katakam P, Mitra A, Chandu BR. Comparative evaluation of hypoglycemic potentials of eucalyptus spp. leaf extracts and their encapsulations for controlled delivery. J Pharm Drug Deliv Res. 2014;3(2).
10. Alani JI, Davis MD, Yiannias JA. Allergy to cosmetics: a literature review. Dermatitis. 2013 Dec 1;24(6):283-90.
11. Lucca JM, Joseph R, Al Kubaish ZH, Al-Maskeen SM, Alokaili ZA. An observational study on adverse reactions of cosmetics: The need of practice the Cosmetovigilance system. Saudi Pharmaceutical Journal. 2020 Jun 1;28(6):746-53.
12. Dehvari M, Ghaneian MT, Morowatisharifabad MA, Karimi M, Jasemizad T. Knowledge, attitudes and practice of women about adverse effects of cosmetics in Yazd City, Iran. Health Scope. 2018 Feb 28;7(1).
13. Germán NH, de la Luz SG, Asbún-Bojalil J. Design and Validation of a Questionnaire in Pharmacovigilance. International Journal Of Medical Science And Clinical Inventions. 2016;3(10):2226-33.
14. Bilal AI, Tilahun Z, Osman ED, Mulugeta A, Shekabdulahi M, Berhe DF. Cosmetics use-related adverse events and determinants among Jigjiga town residents, Eastern Ethiopia. Dermatology and therapy. 2017 Mar;7:143-53.
15. Namballa M, Adimulapu A, Jesudasan RE. QbD Assisted Optimization of Microwave-assisted Synthesis of Polyacrylamide Grafted Tragacanth: Characterization and Instrumental Analysis. Current Microwave Chemistry. 2024 Apr 1;11(1):16-29.
16. Hamann CR, Bernard S, Hamann D, Hansen R, Thyssen JP. Is there a risk using hypoallergenic cosmetic pediatric products in the United States?. Journal of Allergy and Clinical Immunology. 2015 Apr 1;135(4):1070-1.
17. Fiume M, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. Final report on the safety assessment of sodium cetearyl sulfate and related alkyl sulfates as used in cosmetics. International journal of toxicology. 2010 May;29(3_suppl):115S-32S.
18. Guerra E, Llompart M, Garcia-Jares C. Analysis of dyes in cosmetics: challenges and recent developments. Cosmetics. 2018 Jul 23;5(3):47.
19. Khan AD, Alam MN. Cosmetics and their associated adverse effects: A review. Journal of Applied Pharmaceutical Sciences and Research. 2019 Apr 4:1-6.
Published
30/06/2024
Statistics
92 Views | 84 Downloads
Citatons
How to Cite
Ramisetty, S. “A Brief Article on Cosmetovigilence the Ongoing and Systematic Monitoring of Safety and Adverse Effects of Cosmetics”. International Journal of Health Care and Biological Sciences, Vol. 5, no. 2, June 2024, pp. 12-17, doi:10.46795/ijhcbs.v5i2.613.
Section
Review Articles